EW | Edwards LifesciencesNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$95.19
+$1.93 (+2.07%)

Edwards Lifesciences (EW) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Apr 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $95.19 vs 50 $88.31 / 200 $85.53
Projection
No cross projected
Test
No active test
Last cross
Golden cross 17 Apr 2025 ยท projected 27 bars out ยท tested 4 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $92.01 vs 50 $85.19 / 200 $79.69
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 30 Mar 2026 ยท projected 16 bars out ยท tested 6 bars

4-hour as of 3 Nov 13:30 ET

Price
above both $95.48 vs 50 $88.14 / 200 $88.63
Projection
Golden cross projected in 4 bars
Test
No active test
Last cross
Death cross 2 Oct 2026 bar 1 ยท projected 16 bars out ยท tested 2 bars

Cross history

28
crosses on record since 2017
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Death4-hour16 bars out2 bar cross test
26 May 2026Golden4-hour14 bars outNot tested
week of 30 Mar 2026Golden flatweekly16 bars out6 bar cross test
17 Feb 2026Death4-hour27 bars outNot tested
6 Nov 2025Golden4-hour23 bars outNot tested

About EW

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$284M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.